Form 424B3 BRISTOL MYERS SQUIBB CO
http://archive.fast-edgar.com/20190222/AH2ZQ22CZ2227TL2222C2Z32PUQWZC22XMB2
Filed on: February 22, 2019
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) Announces KRYSTAL-12 Trial of KRAZATI Met Primary Endpoint
- Bristol Myers Squibb Provides Update on the First Phase 3 YELLOWSTONE Trial Evaluating Oral Zeposia (ozanimod) in Patients with Moderate to Severe Active Crohn’s Disease
- Building Your Credit: Applying for Credit Cards Online Responsibly
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!